FDA Drug/Biologics Approval BLA 125276 S-064, TOCILIZUMAB

FDA Drug/Biologics Approval BLA 125276 S-064, TOCILIZUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125276 S-064
Company: GENENTECH
Drug Name: ACTEMRA
Active Ingredients: TOCILIZUMAB
Strength: 400MG/20ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 01/08/2010
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details